CMB
CAMBIUM BIO LIMITED
$0.5400
0.00%
Market cap
$16M
Turnover
—
Last price
$0.5400
Day change
0.00%
Announcements
6
Range, past year
Open 0.475 · Low 0.190 · Now 0.540 · High 0.600
Open CMB in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
CMB momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Trend stage
Neutral
1 Day
+0.0%
1 Week
+0.0%
1 Month
+17.4%
1 Year
+8.0%
RSI
66
Avg daily range
1.7%
Its trend is currently classified as Neutral.
Against the wider market it is currently outperforming and the institutional accumulation signal reads low.
What stands out
- Fresh trend age (29 days)
- RSI in healthy zone (66)
Points to watch
Nothing flagged for CMB on this reading.
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsCMB announcements
Recent price-sensitive releases.
- 2026-09-16 Cambium Bio Secures A$10.85 Million Funding Package Placement | Issued Capital - Other
- 2026-08-28 FY26 Appendix 4E and Annual Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-30 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-07-22 Cambium Bio Raises A$1.0 Million via Placement
- 2026-04-28 Quarterly Activities/Appendix 4C Cash Flow Report
- 2026-04-23 FDA Confirms Single Pivotal Trial Pathway for Elate Ocular
More Health Care stocks
Most traded in the same sector.